Besides, the peptide SATB1565–574 -HLA-I complexes on the surface of normal cells may be too low to reach the threshold for T cell scrutiny; while in cancer cells, over-expression of SATB1 results in increased presentation of the peptide on the cell surface for T cell recognition. Here, SATB1 is linked to cancer.